Christopher Neumann, MD
Neurological Surgery · Lawton, OKNPI 1306051479
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Boston Scientific at 29.3% of the total. That places this record below the midpoint for neurological surgery clinicians in OK, where the typical reported total is $1,952.
Across 41 payments — averaging $26.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$313
- Medtronic$95
- Surgalign Spine Technologies, Inc.$89
- Globus Medical$78
- Xtant Medical Inc$61
- Amneal Pharmaceuticals LLC$60
- plus $372 from 17 others
What the payments were for
- Food & beverage$1,069100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $313 |
| Medtronic | 2 | $95 |
| Surgalign Spine Technologies, Inc. | 1 | $89 |
| Globus Medical | 2 | $78 |
| Xtant Medical Inc | 1 | $61 |
| Amneal Pharmaceuticals LLC | 4 | $60 |
| Neurocrine Biosciences, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $44 |
| AstraZeneca | 2 | $32 |
| Abbott | 2 | $28 |
| Zimvie Inc. | 1 | $26 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| AbbVie | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| UCB, Inc. | 1 | $17 |
| MDD US Operations, LLC | 1 | $16 |
| Pfizer | 1 | $15 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
| Biogen | 1 | $13 |
| Greenwich Biosciences, Inc. | 1 | $12 |
| Baxter Healthcare | 1 | $12 |
| Aprecia Pharmaceuticals, LLC | 1 | $12 |
| CSL Behring | 1 | $12 |
How this compares
$1,069 in reported general payments places this provider in the 35th percentile of 80 neurological surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 55 | $862 |
| Methocarbamol | 22 | $269 |
| Gabapentin | 26 | $196 |
| Oxycodone Hcl | 25 | $169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $142 |
| Tramadol Hcl | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Lawton
- Mark DuncanLawton$1K
- Brian SnellOklahoma City$3.7M
- Fadi NasrOklahoma City$1.6M
- Clinton BairdTulsa$621K
- Robert TibbsOklahoma City$537K
- Michael HahnOklahoma City$267K
- Christopher BarryEdmond$181K
- Isaac KarikariOklahoma City$137K
- Joseph CoxOklahoma City$123K
- Michael ThambuswamyTulsa$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.